CAMK1D and schizophrenia: The direct molecular mechanism through which rs12777434 acts on BMI and schizophrenia is currently unclear; however, variants within CAMK1D have been shown to affect its gene expression, leading to altered glucose processing through decreased gluconeogenesis and increased glycogen storage.